-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
Osteoporosis in the News
DXA Task Force Applauds Introduction of Legislation to Protect Patient Access to Osteoporosis Testing
Osteoporosis in the News
NOF
June 10, 2011
WASHINGTON, D.C., (June 9, 2011) — In an effort to protect patient access to osteoporosis testing and reduce the physical and economic burden of osteoporosis for millions of Americans, Senators Olympia Snowe (R-ME) and Debbie Stabenow (D-MI) and Representatives Michael Burgess (R-26-TX) and Shelley Berkley (D-1-NV) introduced in Congress the “Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011” (S. 1096 and H.R. 2020).
Agency for Healthcare Research and Quality (AHRQ) Releases a New Report on Hip Fracture Pain and Management
Osteoporosis in the News
AHRQ
May 18, 2011
HHS' Agency for Healthcare Research and Quality (AHRQ) would like to make you aware of a new report on hip fracture pain and management. This new Federal report concludes most treatments to relieve pain for patients who suffer a broken hip work at least in the short term, but finds a lack of evidence supporting one treatment over another. In addition, the report highlights an overall lack of high-quality data and evidence.
FDA: Update on Femur Fracture Risk with Bisphosphonates
Osteoporosis in the News
FDA
February 7, 2011
The FDA has issued updated information on atypical fractures of the femur associated with the use of bisphosphonates to treat osteoporosis. These drugs include Fosamax® (alendronate sodium), Actonel® (risedronate sodium), Boniva® (ibandronate sodium), Atelvia™ (risedronate sodium), Reclast® (zoledronic acid), and their generic equivalents.
Click here for more information.
Institute of Medicine (IOM) updates vitamin D recommendations
Osteoporosis in the News
IOM
November 30, 2010
Today the Institute of Medicine (IOM) released updated recommendations regarding calcium and vitamin D intake. IOM recommends 600 international units (IU) of vitamin D every day for most healthy adults under age 71 and 800 IU for healthy people age 71 and older. The updated IOM recommendations for vitamin D intake are sufficient for most healthy adults, however, some adults may need more.
FDA: Possible increased risk of thigh bone fracture with bisphosphonates
Osteoporosis in the News
FDA
October 13, 2010
Labeling change adds warning about possible risks of long-term use of osteoporosis drugs
The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk.
To read more visit, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm
In National Checkup, Women's Health Gets Mixed Grades
Osteoporosis in the News
NBC
September 24, 2010
While a concerted effort to boost research on women's health over the last two decades has lessened the burden cardiovascular disease, breast cancer and cervical cancer, the effort has yielded less progress on other fronts. NBC's Robert Bazell reports.
Bisphosphonates and Reports of Unusual Broken Bones in the Femur (Thigh Bone)
Osteoporosis in the News
NOF
September 21, 2010
What is the concern?
Researchers have been looking into a possible link between the use of bisphosphonate medicines, such as alendronate (Fosamax®), ibandronate (Boniva®), risedronate (Actonel®) and zoledronic acid (Reclast®) and an unusual type of broken bone in the femur (thigh bone). Bisphosphonate medicines are prescribed to reduce the risk of fractures (broken bones) in people with osteoporosis.
Bisphosphonates and Esophageal Cancer
Osteoporosis in the News
NOF
September 13, 2010
What is the concern?
Researchers have been looking into a possible link between the use of oral bisphosphonate medications, such as alendronate (Fosamax®), ibandronate (Boniva®) and risedronate (Actonel®) and an increased risk of esophageal cancer. Bisphosphonate medications are prescribed to reduce the risk of fractures (broken bones).
NOF's Bone Basics on Calcium
Osteoporosis in the News
NOF
August 5, 2010
A recent analysis published in the British Medical Journal suggests a possible link between the use of calcium supplements and risk of hearts attacks.
While more conclusive research is necessary to confirm these findings, you can learn what we currently know about calcium by reading NOF’s Bone Basics on Calcium (PDF).
